These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35563489)

  • 1. Topological and Multivalent Effects in Glycofullerene Oligomers as EBOLA Virus Inhibitors.
    Ramos-Soriano J; Illescas BM; Pérez-Sánchez A; Sánchez-Bento R; Lasala F; Rojo J; Delgado R; Martín N
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivalent Glycosylated Nanostructures To Inhibit Ebola Virus Infection.
    Illescas BM; Rojo J; Delgado R; Martín N
    J Am Chem Soc; 2017 May; 139(17):6018-6025. PubMed ID: 28394600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of giant globular multivalent glycofullerenes as potent inhibitors in a model of Ebola virus infection.
    Muñoz A; Sigwalt D; Illescas BM; Luczkowiak J; Rodríguez-Pérez L; Nierengarten I; Holler M; Remy JS; Buffet K; Vincent SP; Rojo J; Delgado R; Nierengarten JF; Martín N
    Nat Chem; 2016 Jan; 8(1):50-7. PubMed ID: 27055288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of glycofullerene dynamics by NMR spectroscopy.
    Engström O; Muñoz A; Illescas BM; Martín N; Ribeiro-Viana R; Rojo J; Widmalm G
    Org Biomol Chem; 2015 Aug; 13(32):8750-5. PubMed ID: 26186577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudosaccharide functionalized dendrimers as potent inhibitors of DC-SIGN dependent Ebola pseudotyped viral infection.
    Luczkowiak J; Sattin S; Sutkevičiūtė I; Reina JJ; Sánchez-Navarro M; Thépaut M; Martínez-Prats L; Daghetti A; Fieschi F; Delgado R; Bernardi A; Rojo J
    Bioconjug Chem; 2011 Jul; 22(7):1354-65. PubMed ID: 21650462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of chemically synthesized inhibitors of Ebola virus.
    Cardile AP; Mayers DL; Bavari S
    Recent Pat Antiinfect Drug Discov; 2014; 9(2):97-103. PubMed ID: 25808170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection.
    Wu W; Liu S
    Curr Top Med Chem; 2017; 17(3):361-370. PubMed ID: 27572081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.
    Dhama K; Karthik K; Khandia R; Chakraborty S; Munjal A; Latheef SK; Kumar D; Ramakrishnan MA; Malik YS; Singh R; Malik SVS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():1803. PubMed ID: 30147687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Small Molecule Entry Inhibitors of Ebola Virus.
    Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel quinolone derivatives targeting human dihydroorotate dehydrogenase suppress Ebola virus infection in vitro.
    Gong M; Yang Y; Huang Y; Gan T; Wu Y; Gao H; Li Q; Nie J; Huang W; Wang Y; Zhang R; Zhong J; Deng F; Rao Y; Ding Q
    Antiviral Res; 2021 Oct; 194():105161. PubMed ID: 34391783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanocarbon-Based Glycoconjugates as Multivalent Inhibitors of Ebola Virus Infection.
    Rodríguez-Pérez L; Ramos-Soriano J; Pérez-Sánchez A; Illescas BM; Muñoz A; Luczkowiak J; Lasala F; Rojo J; Delgado R; Martín N
    J Am Chem Soc; 2018 Aug; 140(31):9891-9898. PubMed ID: 30014698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannosyl glycodendritic structure inhibits DC-SIGN-mediated Ebola virus infection in cis and in trans.
    Lasala F; Arce E; Otero JR; Rojo J; Delgado R
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3970-2. PubMed ID: 14638512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga.
    Chiramel AI; Banadyga L; Dougherty JD; Falzarano D; Martellaro C; Brees D; Taylor RT; Ebihara H; Best SM
    J Infect Dis; 2016 Oct; 214(suppl 3):S355-S359. PubMed ID: 27511894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24.
    Kwofie SK; Broni E; Teye J; Quansah E; Issah I; Wilson MD; Miller WA; Tiburu EK; Bonney JHK
    Comput Biol Med; 2019 Oct; 113():103414. PubMed ID: 31536833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling Ebola virus dynamics: Implications for therapy.
    Martyushev A; Nakaoka S; Sato K; Noda T; Iwami S
    Antiviral Res; 2016 Nov; 135():62-73. PubMed ID: 27743917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals.
    Hoenen T; Groseth A; Callison J; Takada A; Feldmann H
    Antiviral Res; 2013 Sep; 99(3):207-13. PubMed ID: 23751367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus.
    Barrientos LG; O'Keefe BR; Bray M; Sanchez A; Gronenborn AM; Boyd MR
    Antiviral Res; 2003 Mar; 58(1):47-56. PubMed ID: 12719006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.
    Covés-Datson EM; Dyall J; DeWald LE; King SR; Dube D; Legendre M; Nelson E; Drews KC; Gross R; Gerhardt DM; Torzewski L; Postnikova E; Liang JY; Ban B; Shetty J; Hensley LE; Jahrling PB; Olinger GG; White JM; Markovitz DM
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007595. PubMed ID: 31356611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycofullerenes inhibit viral infection.
    Luczkowiak J; Muñoz A; Sánchez-Navarro M; Ribeiro-Viana R; Ginieis A; Illescas BM; Martín N; Delgado R; Rojo J
    Biomacromolecules; 2013 Feb; 14(2):431-7. PubMed ID: 23281578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
    Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
    Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.